Tremfya was approved by FDA for treating Crohn's Disease. TREMFYA® is the only IL-23i to demonstrate superiority vs STELARA® across all pooled endoscopic endpoints in registrational trials.
Medical treatment for Crohn's Disease is rapidly progressing. There are more tools available than 20-30 years ago.
Haven't heard of this particular medication as of yet. Thanks for posting Paul. Always good to hear about new treatments and what's on the horizon.
All three of the IL-23 inhibitors (Tremfya, Skyrizi, Omvoh) are proving to be statistically superior to Stelara.
Meanwhile, Stelara has lost patent protection, and there are now several biosimilars available as alternatives to Stelara.
Meanwhile, Stelara has lost patent protection, and there are now several biosimilars available as alternatives to Stelara.